A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
Latest Information Update: 18 Jun 2025
At a glance
- Drugs KBL 697 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors KoBioLabs
Most Recent Events
- 18 Jun 2025 New trial record